Phase 2 Lung Cancer Non-Small Cell Cancer (NSCLC) trials recruiting now

All Lung Cancer Non-Small Cell Cancer (NSCLC) trials, every phase

Phase 2 Lung Cancer Non-Small Cell Cancer (NSCLC) trials

• EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC
  NCT07637448 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
  NCT06810609 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 5 locations
• Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
  NCT07405190 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.